Phase I Trial of an Immunotherapeutic Vaccine Targetting Epstein-Barr Virus-Positive Malignancies: Laboratory Studies on Vaccinated Patients

Project Details

Short titlePhase I Trial of an Immunotherapeutic Vaccine Targetting Epstein-Barr Virus-Positive Malignancies: Laboratory Studies on Vaccinated Patients
StatusFinished
Effective start/end date1/01/04 → 31/12/05

Funding

  • Cancer Research UK